PROFOUND MEDICAL CORP.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-9.5M | $-7.1M | $-8.0M | $-15.7M | $-10.7M | $-9.4M | $-6.9M | $-6.6M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $126.0K | $93.0K | $93.0K | $102.0K | $116.0K | $164.0K | $184.0K | $199.0K |
| Amortization | — | $7.0K | — | — | $47.0K | — | — | $51.0K |
| Stock-Based Compensation | — | $1.0M | — | — | $989.0K | — | — | $767.0K |
| Net Cash from Operating Activities | $-11.3M | $-8.6M | $-9.6M | $-13.7M | $-8.3M | $-6.8M | $-6.2M | $-4.5M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | — | — | $-290.0K | — | — | $20.5M |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — | — | — | — |